Reduced activity of the hypertension-associated Lys528Arg mutant of human adipocyte-derived leucine aminopeptidase (A-LAP)/ER-aminopeptidase-1

FEBS Lett. 2006 Mar 20;580(7):1833-8. doi: 10.1016/j.febslet.2006.02.041. Epub 2006 Feb 24.


The adipocyte-derived leucine aminopeptidase (A-LAP)/ER aminopeptidase-1 is a multi-functional enzyme belonging to the M1 family of aminopeptidases. It was reported that the polymorphism Lys528Arg in the human A-LAP gene is associated with essential hypertension. In this study, the role of Lys528 in the enzymatic activity of human A-LAP was examined by site-directed mutagenesis. Among non-synonymous polymorphisms tested, only Lys528Arg reduced enzymatic activity. The replacement of Lys528 with various amino acids including Ala, Met, His and Arg caused a significant decrease in the enzymatic activity. Molecular modeling of the enzyme suggested that Lys528 is located near the entrance of the substrate pocket. These results suggest that Lys528 is important for maximal activity of A-LAP by maintaining the appropriate structure of the substrate pocket of the enzyme. The reduced enzymatic activity of A-LAP may cause high blood pressure and the observed association between the polymorphism and hypertension.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes / enzymology*
  • Amino Acid Sequence
  • Binding Sites
  • Humans
  • Hypertension / etiology
  • Hypertension / genetics*
  • Kinetics
  • Leucyl Aminopeptidase / genetics*
  • Leucyl Aminopeptidase / metabolism
  • Models, Molecular
  • Mutation, Missense*
  • Sequence Alignment


  • Leucyl Aminopeptidase
  • puromycin-insensitive leucyl-specific aminopeptidase